EMERYVILLE, Calif. (AP) — EMERYVILLE, Calif. (AP) — Metagenomi Inc. (MGX) on Tuesday reported a loss of $25 million in its first quarter.

On a per-share basis, the Emeryville, California-based company said it had a loss of 68 cents.

The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 62 cents per share.

The genetic medicines company posted revenue of $4.1 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGX at https://www.zacks.com/ap/MGX